NO20001200L - Pyrrolopyrrolonderivater som inhibitorer av nøyrofil elastase - Google Patents
Pyrrolopyrrolonderivater som inhibitorer av nøyrofil elastaseInfo
- Publication number
- NO20001200L NO20001200L NO20001200A NO20001200A NO20001200L NO 20001200 L NO20001200 L NO 20001200L NO 20001200 A NO20001200 A NO 20001200A NO 20001200 A NO20001200 A NO 20001200A NO 20001200 L NO20001200 L NO 20001200L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- neutrophil elastase
- pyrrolopyrrolone
- derivatives
- pyrrolopyrrolone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Det er beskrevet en forbindelser med formel (I) (I) (relative stereokjemi angitt) hvor R1, R2 og R3 er som definert i beskrivelsen. Forbindelser med formel (l) er nyttige bl.a. ved behandling av inflammatoriske sykdommer i luftveiene.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9719187.8A GB9719187D0 (en) | 1997-09-09 | 1997-09-09 | Compounds |
PCT/EP1998/005604 WO1999012931A1 (en) | 1997-09-09 | 1998-09-07 | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20001200D0 NO20001200D0 (no) | 2000-03-08 |
NO20001200L true NO20001200L (no) | 2000-05-08 |
Family
ID=10818820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20001200A NO20001200L (no) | 1997-09-09 | 2000-03-08 | Pyrrolopyrrolonderivater som inhibitorer av nøyrofil elastase |
Country Status (24)
Country | Link |
---|---|
US (1) | US6228853B1 (no) |
EP (1) | EP1019406A1 (no) |
JP (1) | JP2001515902A (no) |
KR (1) | KR20010023830A (no) |
CN (1) | CN1278821A (no) |
AP (1) | AP2000001760A0 (no) |
AU (1) | AU9536098A (no) |
BR (1) | BR9811651A (no) |
CA (1) | CA2303249A1 (no) |
EA (1) | EA200000205A1 (no) |
EE (1) | EE200000137A (no) |
GB (1) | GB9719187D0 (no) |
HR (1) | HRP20000136A2 (no) |
HU (1) | HUP0003475A3 (no) |
ID (1) | ID24364A (no) |
IL (1) | IL134935A0 (no) |
IS (1) | IS5394A (no) |
MA (1) | MA26544A1 (no) |
NO (1) | NO20001200L (no) |
PL (1) | PL339186A1 (no) |
SK (1) | SK3242000A3 (no) |
TR (1) | TR200001026T2 (no) |
WO (1) | WO1999012931A1 (no) |
ZA (1) | ZA988162B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2805818B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant |
US7745226B2 (en) * | 2005-04-06 | 2010-06-29 | Quest Diagnostics Investments Incorporated | Methods for detecting vitamin D metabolites |
US7972868B2 (en) | 2007-11-28 | 2011-07-05 | Quest Diagnostics Investments Incorporated | Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry |
US7977117B2 (en) | 2009-12-03 | 2011-07-12 | Quest Diagnostics Investments Incorprated | Vitamin D metabolite determination utilizing mass spectrometry following derivatization |
CA2783797C (en) | 2009-12-11 | 2021-06-08 | Quest Diagnostics Investments Incorporated | Mass spectrometric determination of non-derivatized, non-metabolized vitamin d |
CN102812356B (zh) | 2009-12-11 | 2017-08-08 | 奎斯特诊断投资公司 | 多重样品中的甾族化合物的质谱法 |
WO2021053058A1 (en) | 2019-09-17 | 2021-03-25 | Mereo Biopharma 4 Limited | Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease |
MX2022012942A (es) | 2020-04-16 | 2023-01-11 | Mereo Biopharma 4 Ltd | Metodos que involucran el inhibidor de la elastasa de neutrofilo alvelestat para el tratamiento de enfermedades respiratorias mediadas por deficiencia de alfa-1 antitripsina. |
AU2022373971A1 (en) | 2021-10-20 | 2024-04-04 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3983245A (en) * | 1975-02-06 | 1976-09-28 | Smithkline Corporation | Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes |
GB8512230D0 (en) | 1985-05-14 | 1985-06-19 | Shell Internationale Researche | Preparation of carboxylic acid salt |
GB9211783D0 (en) * | 1992-06-04 | 1992-07-15 | Ici Plc | Amide derivatives |
GB9402680D0 (en) * | 1994-02-11 | 1994-04-06 | Zeneca Ltd | Pyrrolidine derivatives |
HUP9900973A3 (en) * | 1996-01-03 | 2000-04-28 | Smithkline Beecham Plc | Carbamoyloxy derivatives of mutiline with antibacterial activity, pharmaceutical compns. contg. them and process for preparing the said compds. |
KR20000005039A (ko) * | 1996-03-28 | 2000-01-25 | 그레이엄 브레레톤, 레슬리 에드워즈 | 호중구 엘라스타제 억제제로서의 피롤로피롤론 유도체 |
-
1997
- 1997-09-09 GB GBGB9719187.8A patent/GB9719187D0/en not_active Ceased
-
1998
- 1998-09-07 ID IDW20000665A patent/ID24364A/id unknown
- 1998-09-07 BR BR9811651-7A patent/BR9811651A/pt not_active Application Discontinuation
- 1998-09-07 EA EA200000205A patent/EA200000205A1/ru unknown
- 1998-09-07 WO PCT/EP1998/005604 patent/WO1999012931A1/en not_active Application Discontinuation
- 1998-09-07 AU AU95360/98A patent/AU9536098A/en not_active Abandoned
- 1998-09-07 CN CN98810967A patent/CN1278821A/zh active Pending
- 1998-09-07 EP EP98948905A patent/EP1019406A1/en not_active Withdrawn
- 1998-09-07 IL IL13493598A patent/IL134935A0/xx unknown
- 1998-09-07 JP JP2000510738A patent/JP2001515902A/ja active Pending
- 1998-09-07 US US09/508,326 patent/US6228853B1/en not_active Expired - Fee Related
- 1998-09-07 EE EEP200000137A patent/EE200000137A/xx unknown
- 1998-09-07 KR KR1020007002505A patent/KR20010023830A/ko not_active Application Discontinuation
- 1998-09-07 MA MA25244A patent/MA26544A1/fr unknown
- 1998-09-07 HU HU0003475A patent/HUP0003475A3/hu unknown
- 1998-09-07 AP APAP/P/2000/001760A patent/AP2000001760A0/en unknown
- 1998-09-07 PL PL98339186A patent/PL339186A1/xx not_active Application Discontinuation
- 1998-09-07 CA CA002303249A patent/CA2303249A1/en not_active Abandoned
- 1998-09-07 TR TR2000/01026T patent/TR200001026T2/xx unknown
- 1998-09-07 SK SK324-2000A patent/SK3242000A3/sk unknown
- 1998-09-07 ZA ZA9808162A patent/ZA988162B/xx unknown
-
2000
- 2000-03-03 IS IS5394A patent/IS5394A/is unknown
- 2000-03-08 NO NO20001200A patent/NO20001200L/no not_active Application Discontinuation
- 2000-03-09 HR HR20000136A patent/HRP20000136A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ID24364A (id) | 2000-07-13 |
WO1999012931A1 (en) | 1999-03-18 |
US6228853B1 (en) | 2001-05-08 |
EE200000137A (et) | 2001-02-15 |
HUP0003475A2 (hu) | 2001-09-28 |
JP2001515902A (ja) | 2001-09-25 |
TR200001026T2 (tr) | 2000-09-21 |
MA26544A1 (fr) | 2004-12-20 |
CA2303249A1 (en) | 1999-03-18 |
BR9811651A (pt) | 2000-08-08 |
AP2000001760A0 (en) | 2000-03-31 |
PL339186A1 (en) | 2000-12-04 |
HRP20000136A2 (en) | 2000-08-31 |
IS5394A (is) | 2000-03-03 |
HUP0003475A3 (en) | 2002-01-28 |
CN1278821A (zh) | 2001-01-03 |
KR20010023830A (ko) | 2001-03-26 |
IL134935A0 (en) | 2001-05-20 |
NO20001200D0 (no) | 2000-03-08 |
ZA988162B (en) | 2000-03-22 |
EA200000205A1 (ru) | 2000-10-30 |
AU9536098A (en) | 1999-03-29 |
GB9719187D0 (en) | 1997-11-12 |
EP1019406A1 (en) | 2000-07-19 |
SK3242000A3 (en) | 2001-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2216796A1 (en) | Quinazoline derivatives | |
WO2004024081A3 (en) | Acetyl 2-hydroxy-1,3 diaminoalkanes | |
DK0766670T3 (da) | Tri-substituerede phenylderivater anvendelige som PDE IV inhibitorer | |
ATE306261T1 (de) | Antithrombosemittel | |
NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
IL133623A0 (en) | Antithrombotic agents | |
CA2319005A1 (en) | 2-pyridylmethylamine derivatives useful as fungicides | |
NO996108L (no) | 9-oksinerytromycinderivater | |
MY132473A (en) | Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman | |
AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
GEP20074045B (en) | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
NO984470L (no) | Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase | |
WO2001003685A3 (en) | Novel prodrugs for antimicrobial amidines | |
SE9803518D0 (sv) | Novel compounds | |
WO2003030886A3 (en) | Allylamides useful in the treatment of alzheimer's disease | |
NO20001198L (no) | Pyrrolopyrrolondervater som inhibitorer av nøytrofil elastase | |
NO20001200L (no) | Pyrrolopyrrolonderivater som inhibitorer av nøyrofil elastase | |
NO981393L (no) | Guanidinoproteasehemmere | |
CA2309474A1 (en) | New 4-arylpiperidine derivatives for the treatment of pruritus | |
CA2192786A1 (en) | Cyclopeptolide inhibitors of adhesion molecules | |
TNSN05067A1 (en) | Acetyl 2-hydroxy- 1,3 diaminoalkanes | |
NO994131L (no) | Fremgangsmaate for fremstilling av benzotiazolonforbindelser | |
DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus | |
DK0832085T3 (da) | Phosphinsyrederivater med metallopeptidaseinhiberende aktivitet | |
DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |